348 related articles for article (PubMed ID: 27610937)
21. Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL.
Bartholomew TS; Onugha J; Bullock C; Scaramutti C; Patel H; Forrest DW; Feaster DJ; Tookes HE
Harm Reduct J; 2020 Jun; 17(1):40. PubMed ID: 32522201
[TBL] [Abstract][Full Text] [Related]
22. Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting.
Socías ME; Ti L; Wood E; Nosova E; Hull M; Hayashi K; Debeck K; Milloy MJ
Liver Int; 2019 Aug; 39(8):1400-1407. PubMed ID: 30653809
[TBL] [Abstract][Full Text] [Related]
23. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT-An integrated community hepatitis C service.
Phillips C; Schulkind J; O'Sullivan M; Edelman N; Smith HE; Verma S; Jones CJ
J Viral Hepat; 2020 Feb; 27(2):176-187. PubMed ID: 31566851
[TBL] [Abstract][Full Text] [Related]
24. Compulsory drug detention exposure is associated with not receiving antiretroviral treatment among people who inject drugs in Bangkok, Thailand: a cross-sectional study.
Hayashi K; Ti L; Avihingsanon A; Kaplan K; Suwannawong P; Wood E; Montaner JS; Kerr T
Subst Abuse Treat Prev Policy; 2015 May; 10():16. PubMed ID: 25943881
[TBL] [Abstract][Full Text] [Related]
25. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
[TBL] [Abstract][Full Text] [Related]
26. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
[TBL] [Abstract][Full Text] [Related]
27. The impact of border crossing and imprisonment on injection practices and risk of HIV and hepatitis C infection among men who inject drugs in Nepal.
Zaccheo SK; Marrone G; Pandey LR; Deuba K
Int J Drug Policy; 2023 Sep; 119():104145. PubMed ID: 37549595
[TBL] [Abstract][Full Text] [Related]
28. Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugs.
Prouté M; Le Coeur S; Tiv MH; Dub T; Jongpaijitsakul P; Ratnamhin A; Angkurawaranon C; Aramrattana A; Lallemant M
BMC Public Health; 2020 Sep; 20(1):1450. PubMed ID: 32972359
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF
Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097
[TBL] [Abstract][Full Text] [Related]
30. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
[TBL] [Abstract][Full Text] [Related]
31. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.
Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J;
Int J Drug Policy; 2022 Jul; 105():103706. PubMed ID: 35533635
[TBL] [Abstract][Full Text] [Related]
32. Association of co-occurring mental health problems with hepatitis C status among young people who inject drugs in rural New Mexico, 2016-2018.
Gupta A; Shebl FM; Tong Y; Wagner K; Bassett IV; Page K; Winstanley EL
Addict Sci Clin Pract; 2022 Oct; 17(1):58. PubMed ID: 36266666
[TBL] [Abstract][Full Text] [Related]
33. Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH).
Mora M; Goodyear T; Marcellin F; Shoveller J; Di Beo V; Calzolaio C; Sogni P; Wittkop L; Zucman D; Poizot-Martin I; Lacombe K; Salmon-Céron D; Knight R; Carrieri P
J Viral Hepat; 2020 Dec; 27(12):1462-1472. PubMed ID: 32810905
[TBL] [Abstract][Full Text] [Related]
34. Access to HIV treatment and care for people who inject drugs in Kenya: a short report.
Guise A; Rhodes T; Ndimbii J; Ayon S; Nnaji O
AIDS Care; 2016 Dec; 28(12):1595-1599. PubMed ID: 27267309
[TBL] [Abstract][Full Text] [Related]
35. Serious Mental Illness Among Young People Who Inject Drugs: An Assessment of Injection Risks and Healthcare Use.
Adams M; Sionean C; Broz D; Lewis R; Wejnert C;
J Infect Dis; 2020 Sep; 222(Suppl 5):S401-S409. PubMed ID: 32877554
[TBL] [Abstract][Full Text] [Related]
36. Perceived need, barriers to and facilitators of mental health care among HIV-infected PWID in Hanoi, Vietnam: a qualitative study.
Nguyen MX; Go VF; Bui QX; Gaynes BN; Pence BW
Harm Reduct J; 2019 Dec; 16(1):74. PubMed ID: 31878934
[TBL] [Abstract][Full Text] [Related]
37. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS
Elife; 2021 Aug; 10():. PubMed ID: 34342266
[TBL] [Abstract][Full Text] [Related]
38. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.
Alavi M; Grebely J; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S62-9. PubMed ID: 23884068
[TBL] [Abstract][Full Text] [Related]
39. Potential use of supervised injection services among people who inject drugs in a remote and mid-size Canadian setting.
Mitra S; Rachlis B; Krysowaty B; Marshall Z; Olsen C; Rourke S; Kerr T
BMC Public Health; 2019 Mar; 19(1):284. PubMed ID: 30849946
[TBL] [Abstract][Full Text] [Related]
40. "I want to feel young again": experiences and perspectives of young people who inject drugs living with hepatitis C in Vancouver, Canada.
Jacob J; Goodyear T; Coulaud PJ; Hoong P; Ti L; Knight R
Can J Public Health; 2021 Oct; 112(5):947-956. PubMed ID: 34115340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
